Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)

NCT00393705 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Biphasic Aspart 30/70
DRUG: insulin lispro LM
DRUG: insulin lispro MM
DRUG: insulin lispro LM

Sponsor

Eli Lilly and Company